WEBRobert Barrie. News. PharmaJet’s needle-free delivery system proves effective in published study. Jenna Philpott. Analyst Comment. Syphilis, the once near-eliminated STI, is resurging in the US. GlobalData Healthcare. Partner Content. Podcast #1: Doing Digital Deals in Life Sciences | Corporate Culture. News.
DA:10PA:46MOZ Rank:52
U.S. clinical trial results show Novavax vaccine is safe and …
WEBJun 14, 2021 · Results from a Phase 3 clinical trial enrolling 29,960 adult volunteers in the United States and Mexico show that the investigational vaccine known as NVX-CoV2373 demonstrated 90.4% efficacy in preventing symptomatic COVID-19 disease. The candidate showed 100% protection against moderate and severe disease.
WEB08 March 2024. Shifts in the clinical trial landscape. By. Asher Mullard. Drug developers initiated nearly 4,900 clinical trials in 2023, down 15% from 2022 and down 32% from their...
DA:20PA:10MOZ Rank:19
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded
WEBPublished September 22, 2021. N Engl J Med 2021;385: 1774 - 1785. DOI: 10.1056/NEJMoa2113017. VOL. 385 NO. 19. Abstract. Background. At interim analysis in a phase 3, observer-blinded,...
DA:49PA:90MOZ Rank:1
11 clinical trials that will shape medicine in 2023 - Nature
WEBDec 23, 2022 · Nature Medicine asks leading researchers to name their top clinical trial for 2023, from cervical and prostate cancer screening to new drugs for Parkinson’s disease and Alzheimer’s disease.
WEBApr 17, 2024 · By Jonathan Gardner • April 15, 2024. Neumora’s schizophrenia drug hit with clinical hold. Shares of the biotech dipped by double digits following disclosure the FDA had paused an early-stage study of Neumora’s muscarinic-targeting drug. By Jacob Bell • April 15, 2024. Ultragenyx says Angelman therapy is working, but safety questions remain.
WEB07 December 2023. Correction 18 December 2023. CRISPR 2.0: a new wave of gene editors heads for clinical trials. Landmark approval of the first CRISPR therapy paves the way for treatments based...
DA:52PA:90MOZ Rank:13
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
WEBApr 24 | Clinical Research News | Metsera has launched and will rapidly advance a broad portfolio of oral and injectable incretin, nonincretin, and combination therapies designed to meet the future needs of a rapidly evolving weight loss treatment landscape; Obsidian Therapeutics plans to advance its lead engineered tumor-infiltrating lymphocyte...